In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern

Published:2021-12-13 Issue:1 Volume:28 Page:
ISSN:1573-3149
Container-title:International Journal of Peptide Research and Therapeutics
language:en
Short-container-title:Int J Pept Res Ther

Author:

Rajpoot Sajjan,Solanki Kundan,Kumar Ashutosh,Zhang Kam Y. J.,Pullamsetti Soni Savai,Savai Rajkumar,Faisal Syed M.,Pan Qiuwei,Baig Mirza S.

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10989-021-10339-0.pdf

Reference51 articles.

1. Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl EJS (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1(1):19–25. https://doi.org/10.1016/j.softx.2015.06.001

2. Baig MS, Alagumuthu M, Rajpoot S, Saqib U (2020) Identification of a potential peptide inhibitor of SARS-CoV-2 targeting its entry into the host cells. Drugs R D 20(3):161–169. https://doi.org/10.1007/s40268-020-00312-5

3. Bian J, Li Z (2021) Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm Sin B 11(1):1–12. https://doi.org/10.1016/j.apsb.2020.10.006

4. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77(16):8801–8811. https://doi.org/10.1128/jvi.77.16.8801-8811.2003

5. Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81(1):136–147. https://doi.org/10.1111/cbdd.12055

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants;Drugs and Drug Candidates;2024-01-05

2. SARS-CoV-2 Spike Protein: A Review of Structure, Function, Care, Vaccines, and Possible Inhibitors Designed by Molecular Modeling;Trends and Innovations in Energetic Sources, Functional Compounds and Biotechnology;2023-12-01

3. Deep learning tools to accelerate antibiotic discovery;Expert Opinion on Drug Discovery;2023-10-04

4. Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein–human ACE2 interaction;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-08-21

5. De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection;The Journal of Infectious Diseases;2023-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3